A Comparison of Tiotropium 18microgram, Once Daily and Ipratropium 40microgram, 4 Times Daily in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults with Chronic Obstructive Pulmonary Disease.
Seung Joon Kim, Myung Sook Kim, Sang Haak Lee, Young Kyoon Kim, Hwa Sik Moon, Sung Hak Park, Sang Yeub Lee, Kwang Ho In, Chang Youl Lee, Young Sam Kim, Hyung Jung Kim, Chul Min Ahn, Sung Kyu Kim, Kyung Rok Kim, Seung Ick Cha, Tae Hoon Jung, Mi Ok Kim, Sung Soo Park, Cheon Woong Choi, Jee Hong Yoo, Hong Mo Kang, Won Jung Koh, Hyoung Suk Ham, Eun Hae Kang, O Jung Kwon, Yang Deok Lee, Heung Bum Lee, Yong Chul Lee, Yang Keun Rhee, Won Hyuk Shin, Sung Yeon Kwon, Woo Jin Kim, Chul Gyu Yoo, Young Whan Kim, Young Soo Shim, Sung Koo Han, Hye Kyung Park, Yun Seong Kim, Min Ki Lee, Soon Kew Park, Mi Hye Kim, Won Yeon Lee, Suk Joong Yong, Kye Chul Shin, Byoung Whui Choi, Yeon Mok Oh, Chae Man Lim, Sang Do Lee, Woo Sung Kim, Dong Soon Kim, Sung Soo Jung, Ju Ock Kim, Young Chun Ko, Young Chul Kim, Nam Soo Yoo
Tuberc Respir Dis. 2005;58(5):498-506.   Published online 2005 May 1     DOI: https://doi.org/10.4046/trd.2005.58.5.498
Citations to this article as recorded by Crossref logo
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease
Leanne Cheyne, Melanie J Irvin-Sellers, John White
Cochrane Database of Systematic Reviews.2015;[Epub]     CrossRef
Issues on Safety of Long-Acting Muscarinic Antagonist
Yang Deok Lee, Yongseon Cho, Min Soo Han
Tuberculosis and Respiratory Diseases.2011; 70(5): 384.     CrossRef
Pharmacotherapy in Stable Chronic Obstructive Pulmonary Disease
Young Kyoon Kim
Journal of the Korean Medical Association.2006; 49(4): 333.     CrossRef